USAdvisors Wealth Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,869
| Closed | -$12K | – | 130 |
|
|
2023
Q3 | $12K | Hold |
10,869
| – | – | 0.01% | 105 |
|
|
2023
Q2 | $15K | Hold |
10,869
| – | – | 0.01% | 103 |
|
|
2023
Q1 | $16K | Hold |
10,869
| – | – | 0.01% | 114 |
|
|
2022
Q4 | $13K | Hold |
10,869
| – | – | 0.01% | 109 |
|
|
2022
Q3 | $12K | Buy |
+10,869
| New | +$12K | 0.01% | 114 |
|
|
2022
Q2 | – | Sell |
-10,869
| Closed | -$17K | – | 114 |
|
|
2022
Q1 | $17K | Buy |
+10,869
| New | +$17K | 0.01% | 125 |
|